Valsartan suppresses cardiovascular events in hypertensive subjects with diabetes mellitus (DM) comparable to those with impaired glucose tolerance (IGT)

被引:0
|
作者
Kondo, T. [1 ]
Yamashita, K. [1 ]
Muramatsu, T. [1 ]
Matsushita, K. [1 ]
Nagahiro, T. [1 ]
Maeda, K. [1 ]
Shintani, S. [1 ]
Murohara, T. [1 ]
机构
[1] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:679 / 680
页数:2
相关论文
共 50 条
  • [21] Toxic trace element pattern in patients with Non Insulin Dependant Diabetes Mellitus (NIDDM), impaired glucose tolerance (IGT) and impaired fasting glucose (IFG)
    Serdar, M. A.
    Bakir, F.
    Hasimi, A.
    Celik, T.
    Akin, O.
    Kenar, L.
    Aykut, O.
    Yildirimkaya, M.
    CLINICAL CHEMISTRY, 2008, 54 (06) : A142 - A142
  • [22] Autoimmune Thyroiditis, Type 2 Diabetes Mellitus, Impaired Fasting Glucose, Impaired Glucose Tolerance and Cardiovascular Risk Factors
    Neves, Celestino
    Alves, Marta
    Pereira, Miguel
    Ramalho, Renata
    Carvalho, Ema
    Pimentel, Isolina
    Carvalho, Davide
    Guimaraes, Cristina
    Ramos, Joao Pedro
    Delgado, Luis
    Medina, Jose Luis
    DIABETES, 2010, 59 : A356 - A356
  • [23] Hypertension and associated cardiovascular risk factors in subjects with diabetes, impaired glucose tolerance and normal
    Lazzari, P.
    Zoppi, A.
    Fogari, R.
    JOURNAL OF HYPERTENSION, 2007, 25 : S72 - S72
  • [24] IMPAIRED GLUCOSE-TOLERANCE (IGT), GESTATIONAL DIABETES, AND NONINSULIN DIABETES-MELLITUS (NIDDM) IN CAYO SANTIAGO MACACA-MULATTA
    HOWARD, C
    KESSLER, M
    SCHWARTZ, S
    AMERICAN JOURNAL OF PRIMATOLOGY, 1985, 8 (04) : 344 - 344
  • [25] Risk factors for fatal and non-fatal cardiovascular events in 9306 subjects in the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial
    Mcmurray, J. J. V.
    Laakso, M.
    Standl, E.
    Tognoni, G.
    Holman, R. R.
    Giles, T.
    Martinez, F.
    Thomas, L.
    Haffner, S. M.
    Califf, R. M.
    EUROPEAN HEART JOURNAL, 2011, 32 : 287 - 287
  • [26] Glucose fluctuations in subjects with normal glucose tolerance, impaired glucose regulation and newly diagnosed type 2 diabetes mellitus
    Wang, Chun
    Lv, Lifang
    Yang, Yanzhi
    Chen, Dawei
    Liu, Guanjian
    Chen, Lihong
    Song, Yuanxia
    He, Liping
    Li, Xiujun
    Tian, Haoming
    Jia, Weiping
    Ran, Xingwu
    CLINICAL ENDOCRINOLOGY, 2012, 76 (06) : 810 - 815
  • [27] Association of Sudomotor Function with Glucose Tolerance Status in Subjects with Normal Glucose Metabolism, Impaired Glucose Metabolism, and Diabetes Mellitus
    Oh, Tae Jung
    Lim, Soo
    Lee, Seo Young
    Yang, Ye Seul
    Ji, Myoung Jin
    Min, Se Hee
    Bae, Jae Hyun
    Kim, Kyoung Min
    Moon, Jae Hoon
    Choi, Sung Hee
    Jang, Hak Chul
    DIABETES, 2017, 66 : A152 - A152
  • [28] Cardiovascular risk factors of nondiabetic obese and/or hypertensive subjects with isolated impaired fasting glycemia or isolated impaired glucose tolerance
    Hidvégi, T
    Jermendy, G
    Nádas, J
    Hetytési, K
    Bíró, L
    DIABETES, 2005, 54 : A585 - A585
  • [29] Screen detected subjects with type 2 diabetes and impaired glucose tolerance have more adverse cardiovascular risk than subjects with impaired fasting glucose
    Gorter, K. J.
    Janssen, P. G. H.
    Stolk, R. P.
    Rutten, G. E. H.
    DIABETOLOGIA, 2006, 49 : 226 - 227
  • [30] From impaired glucose tolerance (IGT) to non-insulin dependent diabetes mellitus (NIDDM). Retrospective analysis of 632 observations
    Guarneri, G
    Lavagnini, T
    Maran, A
    Tiengo, A
    DelPrato, S
    DIABETOLOGIA, 1996, 39 : 800 - 800